(RTTNews) - Aligos Therapeutics, Inc. (ALGS) has reported recent business progress and outlined continued advancement across its pipeline of drug candidates purpose-built for liver and viral diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results